Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson’s Disease and Movement Disorders

– Wearable sensors strongly correlated with clinical scales on motor impairment – – bioMUSE Study Validates Use of Wearable Sensors for Alterity’s Ongoing Phase 2 Clinical Trial – MELBOURNE, Australia and SAN FRANCISCO, Sept. 26, 2022 /PRNewswire/ — Alterity Therapeutics (ASX: ATH,…